Enhanced cytotoxic effects of Clinacanthus nutans and doxorubicin in combination toward breast cancer cell lines

Breast cancer is one of the most common cancers with a relatively high mortality rate. Despite the advancement of its medical treatments, many patients are still seeking complementary alternative medicines, namely Clinacanthus nutans which is found mainly in South-East Asian countries. We aim to fin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of advanced pharmaceutical technology and research 2021-04, Vol.12 (2), p.152-156
Main Authors: Widjaja, Sry, Ichwan, M
Format: Article
Language:English
Subjects:
Acetic acid
Alternative medicine
Anthracyclines
antioxidant
Antioxidants
Biological products
Breast cancer
Care and treatment
Cell proliferation
Clinacanthus nutans
cytotoxic
Cytotoxicity
Doxorubicin
Ethanol
Ethyl acetate
Health aspects
Homeopathy
Materia medica and therapeutics
Medical treatment
n-Hexane
Organic compounds
Original
Plant extracts
Therapeutics
Tumor cell lines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Breast cancer is one of the most common cancers with a relatively high mortality rate. Despite the advancement of its medical treatments, many patients are still seeking complementary alternative medicines, namely Clinacanthus nutans which is found mainly in South-East Asian countries. We aim to find the antioxidant properties and cytotoxic activity of the plant extract toward breast cancer cell lines Michigan Cancer Foundation-7 (MCF7) and T47D individually and in combination with doxorubicin. Extractions of C. nutans with ethanol, n-hexane, and ethyl acetate were done using rotatory vacuum evaporators with the reflux method. Screening of biochemical properties was conducted. Antioxidant activity was measured toward α, α-diphenyl-β-picrylhydrazyl (DPPH) with IC50 scores were shown to be highest in ethyl acetate extract. Cytotoxic effects of all three extracts were shown to be low in both MCF7 and T47D cells. However, combinations of 125 μg/ml n-hexane extract of C. nutans, and 0.1 μg/ml doxorubicin in T47D cancer cells showed further proliferation reduction compared to the single administration. The results suggested possible synergisms of the treatment combination.
ISSN:2231-4040
0976-2094
DOI:10.4103/japtr.JAPTR_251_20